Lack of Foxp3+ macrophages in both untreated and B16 melanoma-bearing mice.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2012-02-02
Metadata
Show full item recordThe following license files are associated with this item:
Related articles
- Stress-induced Norepinephrine Downregulates CCL2 in Macrophages to Suppress Tumor Growth in a Model of Malignant Melanoma.
- Authors: Steinberger KJ, Bailey MT, Gross AC, Sumner LA, Voorhees JL, Crouser N, Curry JM, Wang Y, DeVries AC, Marsh CB, Glaser R, Yang EV, Eubank TD
- Issue date: 2020 Sep
- Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
- Authors: Furudate S, Fujimura T, Kambayashi Y, Kakizaki A, Hidaka T, Aiba S
- Issue date: 2017 Jul
- Adenosine A(2B) receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells.
- Authors: Kaji W, Tanaka S, Tsukimoto M, Kojima S
- Issue date: 2014 Apr
- Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location.
- Authors: Kakinuma T, Nadiminti H, Lonsdorf AS, Murakami T, Perez BA, Kobayashi H, Finkelstein SE, Pothiawala G, Belkaid Y, Hwang ST
- Issue date: 2007 Jul
- Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma.
- Authors: Cintolo JA, Datta J, Xu S, Gupta M, Somasundaram R, Czerniecki BJ
- Issue date: 2016 Feb